MENU
PLRX
AS OF
Dec 12 closing price
Price
$1.23
Change
-$0.09 (-6.82%)
Capitalization
75.58M
80 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
PLRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Pliant Therapeutics (PLRX) Ownership - Who owns Pliant Therapeutics?

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
260 Littlefield Avenue
Phone
+1 650 481-6770
Employees
158
Web
https://www.pliantrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
75.58M
P/E Ratio
N/A
Total Cash
241.8M
Projected Growth
N/A
Total Debt
59.86M
Revenue
N/A
Risk (Beta)
1.82
Dividend Yield
N/A
Total Cash/Share
3.93
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

PLRX
Capitalization
75.6M
P/E Ratio
N/A
Risk (Beta)
1.82
Dividend Yield
N/A
Total Cash
242M
Total Cash/Share
3.93
Total Debt
59.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
200M
P/B Ratio
0.38
Cash Flow
N/A
Earnings
-2.86
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
13.93
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-170.45M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-48.60
Shares Held By Institutions
85.7M
Shares Outstanding - Current
61.4M
Total Liabilities
76.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
-89.977
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PLRX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PLRX showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for PLRX
A.I. Advisor
published General Information

General Information

a company which engages in the business of developing and commercializing novel therapies for fibrotic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
260 Littlefield Avenue
Phone
+1 650 481-6770
Employees
158
Web
https://www.pliantrx.com